FDA approves crizanlizumab-tmca for sickle cell disease | "Anemia and blood transfusion in critically ill patients" |
---|---|
Iron: Fact sheet for health professionals | "The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States" |
Vincent JL, Baron JF, Reinhart K; et al | National Heart, Lung, and Blood Institute |
---|---|
FDA approves novel treatment to target abnormality in sickle cell disease | McIntyre LA, Fergusson DA, Hutchison JS; et al |
Pruthi RK expert opinion Mayo Clinic.